| Name | Title | Contact Details |
|---|
Computer Consulting Assoc is a Southport, CT-based company in the Business Services sector.
Third Harmonic Bio is a clinical-stage biopharmaceutical company developing a highly selective, oral KIT inhibitor for treatment of dermal, respiratory and gastrointestinal inflammatory diseases. KIT is a cell surface receptor that acts as the master survival and functional regulator of mast cells, which are immune cells concentrated at the bodys interfaces with the external environment and that act as the key mediator of the inflammation associated with mast-cell mediated inflammatory diseases. By inhibiting KIT, we believe we can provide broad symptomatic relief to patients with a range of disorders, including chronic spontaneous urticaria and severe asthma.
MFA – Moody, Famiglietti and Andronico, LLP is a proactive CPA and consulting firm located North of Boston with National and Global reach. Founded in 1982, the firm is comprised of over 140 professionals including 17 partners whose speed, precision, and commitment to client success consistently results in proven best value solutions that offer the ideal combination of expertise, service and price. In addition, MFA offers through affiliates complementary solutions such as wealth advisory, valuation, business performance enhancement services, IT consulting, fraud and forensic accounting, litigation support and professional staffing.
Gavin Group is a New York, NY-based company in the Business Services sector.
Metsera is a clinical-stage biopharmaceutical company based in New York City, dedicated to developing innovative treatments for obesity and metabolic diseases. Founded in 2022 by Population Health Partners and ARCH Venture Partners, the company has raised $290 million from prominent healthcare investors to support its research and development initiatives. Metsera is advancing a diverse portfolio of oral and injectable therapies, including incretin, non-incretin, and combination treatments. These therapies target various aspects of weight loss and are developed from a proprietary library of over 20,000 gut hormone peptides and peptide/antibody conjugates. A notable partnership with Amneal Pharmaceuticals focuses on the development and supply of its investigational weight loss therapy, MET-097.